Literature DB >> 6324427

Specificity and regulation of cytotoxic T-lymphocyte responses analyzed with H-2 mutants.

C J Melief, M J Stukart, L P de Waal, W M Kast, R W Melvold.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6324427

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

1.  Biochemical analysis of related, independently arising histocompatibility mutants: bm17 and KB-98 enlarge the "bg series" of H-2Kb mutants.

Authors:  G M Pfaffenbach; R W Melvold; S G Nathenson
Journal:  Biochem Genet       Date:  1990-08       Impact factor: 1.890

2.  A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells.

Authors:  R J Moots; M Matsui; L Pazmany; A J McMichael; J A Frelinger
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization.

Authors:  Yi T Koh; Andrew Gray; Sean A Higgins; Bolyn Hubby; W Martin Kast
Journal:  Prostate       Date:  2009-05-01       Impact factor: 4.104

4.  Three spontaneous H-2Db mutants are generated by genetic micro-recombination (gene conversion) events. Impact on the H-2-restricted immune responsiveness.

Authors:  S Hemmi; J Geliebter; R A Zeff; R W Melvold; S G Nathenson
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

5.  Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities.

Authors:  C A Holt; K Osorio; F Lilly
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

6.  Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC-restricted and MHC-regulated; a model for MHC-disease associations.

Authors:  W M Kast; A M Bronkhorst; L P de Waal; C J Melief
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.